Cargando…
Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient
Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The spectrum of symptomatic infection ranges from mild to critical with multiple severe complications. Many vaccines have been developed to prevent COVID‐19 disease, including an mRNA vacci...
Autores principales: | Kultawanich, Kwanhatai, Sampattavanich, Nattaporn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675867/ https://www.ncbi.nlm.nih.gov/pubmed/36415713 http://dx.doi.org/10.1002/ccr3.6610 |
Ejemplares similares
-
Severe bullous drug reaction after COVID‐19 mRNA vaccination
por: Irmer, Marie Luise, et al.
Publicado: (2022) -
Bullous cutaneous reactions
por: Jira, Mohamed, et al.
Publicado: (2018) -
Clinicopathological features of cutaneous reactions after mRNA‐based COVID‐19 vaccines
por: Tihy, M., et al.
Publicado: (2021) -
Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19
por: Juárez Guerrero, Alba, et al.
Publicado: (2021) -
Bullous hemorrhagic dermatosis: A rare cutaneous reaction of heparin
por: Dhattarwal, N, et al.
Publicado: (2023)